econazole and oxiconazole

econazole has been researched along with oxiconazole in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19906 (54.55)18.7374
1990's2 (18.18)18.2507
2000's1 (9.09)29.6817
2010's2 (18.18)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Bakmiwewa, SM; Ball, HJ; Fatokun, AA; Hunt, NH; Payne, RJ; Tran, A1
Bron, S; Chambon, M; Colau, D; Majjigapu, SR; Michielin, O; Pilotte, L; Röhrig, UF; Turcatti, G; Van den Eynde, BJ; Vogel, P; Zoete, V1
Frosch, PJ; Raulin, C1
Bastide, JM; Bastide, M; Jouvert, S; Lebecq, JC; Mallie, M; Montes, B1
Abbott, AB; Odds, FC; Webster, CE1
Gip, L1
Gouveia, DC; Jones da Silva, C1
Bauer, E; Stüttgen, G1
Orengo, I; Rosen, T; Schell, BJ1
Benko, I; Hernádi, F; Kiss, A; Kovács, P; Kraicsovits, F; Megyeri, A; Somogyi, G; Tegyey, Z1

Trials

3 trial(s) available for econazole and oxiconazole

ArticleYear
Comparison of oxiconazole (Ro 13-8996) and econazole in dermatomycoses.
    Mykosen, 1984, Volume: 27, Issue:6

    Topics: Adolescent; Adult; Aged; Antifungal Agents; Candidiasis, Cutaneous; Child; Clinical Trials as Topic; Dermatomycoses; Double-Blind Method; Econazole; Female; Humans; Imidazoles; Male; Middle Aged; Ointments; Tinea Versicolor

1984
Oxiconazole in the treatment of vaginal candidiasis: single dose versus 3-day treatment with econazole.
    Pharmatherapeutica, 1984, Volume: 3, Issue:10

    Topics: Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Drug Administration Schedule; Econazole; Female; Humans; Imidazoles; Middle Aged; Random Allocation

1984
Anti-inflammatory activity of antifungal preparations.
    International journal of dermatology, 1997, Volume: 36, Issue:10

    Topics: Adult; Allylamine; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antifungal Agents; Chemoprevention; Ciclopirox; Double-Blind Method; Econazole; Erythema; Female; Humans; Hydrocortisone; Imidazoles; Ketoconazole; Male; Middle Aged; Naphthalenes; Pyridones; Terbinafine; Ultraviolet Rays

1997

Other Studies

8 other study(ies) available for econazole and oxiconazole

ArticleYear
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Identification of selective inhibitors of indoleamine 2,3-dioxygenase 2.
    Bioorganic & medicinal chemistry letters, 2012, Dec-15, Volume: 22, Issue:24

    Topics: Animals; Dose-Response Relationship, Drug; Enzyme Inhibitors; HEK293 Cells; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Mice; Models, Molecular; Molecular Structure; Structure-Activity Relationship; Substrate Specificity

2012
Detailed analysis and follow-up studies of a high-throughput screening for indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors.
    European journal of medicinal chemistry, 2014, Sep-12, Volume: 84

    Topics: Animals; Antifungal Agents; Dose-Response Relationship, Drug; Enzyme Inhibitors; High-Throughput Screening Assays; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Mice; Molecular Dynamics Simulation; Molecular Structure; Structure-Activity Relationship

2014
Contact allergy to imidazole antimycotics.
    Contact dermatitis, 1988, Volume: 18, Issue:2

    Topics: Adult; Aged; Antifungal Agents; Chemical Phenomena; Chemistry; Clotrimazole; Drug Eruptions; Econazole; Female; Humans; Imidazoles; Male; Miconazole; Middle Aged; Prospective Studies

1988
[Comparative action of 8 azole derivatives against Candida albicans: fungistatic action and cytologic study by scanning electron microscopy].
    Pathologie-biologie, 1988, Volume: 36, Issue:5

    Topics: Antifungal Agents; Candida albicans; Clotrimazole; Cytoplasm; Econazole; Imidazoles; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Microscopy, Electron, Scanning; Spheroplasts; Triazoles

1988
Antifungal relative inhibition factors: BAY l-9139, bifonazole, butoconazole, isoconazole, itraconazole (R 51211), oxiconazole, Ro 14-4767/002, sulconazole, terconazole and vibunazole (BAY n-7133) compared in vitro with nine established antifungal agents.
    The Journal of antimicrobial chemotherapy, 1984, Volume: 14, Issue:2

    Topics: Antifungal Agents; Aspergillus; Candida; Clotrimazole; Econazole; Imidazoles; In Vitro Techniques; Itraconazole; Ketoconazole; Miconazole; Morpholines; Triazoles

1984
Bioavailability, skin- and nailpenetration of topically applied antimycotics.
    Mykosen, 1982, Volume: 25, Issue:2

    Topics: Administration, Topical; Antifungal Agents; Biological Availability; Econazole; Humans; Imidazoles; Morpholines; Nails; Skin

1982
Comparison of the toxicity of fluconazole and other azole antifungal drugs to murine and human granulocyte-macrophage progenitor cells in vitro.
    The Journal of antimicrobial chemotherapy, 1999, Volume: 43, Issue:5

    Topics: Animals; Antifungal Agents; Azoles; Bone Marrow; Cells, Cultured; Clotrimazole; Dose-Response Relationship, Drug; Econazole; Female; Fluconazole; Granulocytes; Hematopoietic Stem Cells; Humans; Imidazoles; Inhibitory Concentration 50; Ketoconazole; Macrophages; Male; Mice; Miconazole; Species Specificity; Stem Cells

1999